2019
DOI: 10.1016/j.ajoc.2018.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Clinical findings of end-stage retinitis pigmentosa with a homozygous PDE6A variant (p.R653X)

Abstract: PurposeTo report clinical and genetic features of a Japanese patient with end-stage retinitis pigmentosa (RP) caused by a homozygous PDE6A variant.MethodsWe performed comprehensive ophthalmic examinations. Whole exome sequencing analysis was used to investigate the RP patient with parental consanguinity. The pedigree included 4 RP patients in the two generations, which suggests presumed pseudo-autosomal dominant inheritance.ResultsA PDE6A variant (p.R653X) was identified to be homozygous and disease-causing in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“… 4 Rods have a PDE6 catalytic core composed of a heterodimer of PDE6A and PDE6B subunits (inhibited by PDE6G), whereas cones have a catalytic homodimer of PDE6C (inhibited by PDE6H subunits). 5 This explains why mutations in PDE6A (OMIM #180071), PDE6B (OMIM #180072) and PDE6G (OMIM #180073) cause autosomal recessive retinitis pigmentosa and autosomal dominant congenital stationary night blindness (both rod-related diseases), 6 , 7 whereas homozygous or compound heterozygous mutations in PDE6C and PDE6H (OMIM #600827 and #601190) lead to predominantly cone dysfunction disorders, such as achromatopsia (ACHM) and autosomal recessive cone dystrophy. 8 , 9 …”
mentioning
confidence: 99%
“… 4 Rods have a PDE6 catalytic core composed of a heterodimer of PDE6A and PDE6B subunits (inhibited by PDE6G), whereas cones have a catalytic homodimer of PDE6C (inhibited by PDE6H subunits). 5 This explains why mutations in PDE6A (OMIM #180071), PDE6B (OMIM #180072) and PDE6G (OMIM #180073) cause autosomal recessive retinitis pigmentosa and autosomal dominant congenital stationary night blindness (both rod-related diseases), 6 , 7 whereas homozygous or compound heterozygous mutations in PDE6C and PDE6H (OMIM #600827 and #601190) lead to predominantly cone dysfunction disorders, such as achromatopsia (ACHM) and autosomal recessive cone dystrophy. 8 , 9 …”
mentioning
confidence: 99%
“… NA NA NA NA 0.0080% Yes [ 11 13 ] P03 PDE6A c.2275-2A > G p.? NA NA NA NA 0% Yes [ 14 ] PDE6A c.1957C > T p. Arg653* NA NA NA NA 0.0028% Yes [ 15 ] P04 PDE6A c.1747 T > A p. Tyr583Asn Possibly damaging Disease causing Tolerated Deleterious 0% No PDE6A c.1651A > G p. Lys551Glu Benign Disease causing Deleterious Deleterious 0% Yes [ 10 ] OPTN c.1634G > A p. Arg545Gln Benign Disease causing Tolerated Neutral 0.3103% Yes [ 16 , 17 ] P05 PDE6A c.1651A > G p. Lys551Glu Benign Disease causing Deleterious Deleterious 0% Yes [ 10 ] PDE6A c.285C > A p. Ser95Arg Possibly damaging Disease causing Deleterious Deleterious 0% Yes [ 10 ] P06 PDE6B c.401 T > C p. Leu134Pro Probably damaging Disease causing Deleterio...…”
Section: Resultsmentioning
confidence: 99%
“…RP used to be called pigmentary retinopathy, the typical clinical features are bilateral progressive peripheral visual eld defect, night blindness, retinal bone spicule intraretinal pigmentation,abnormal electroretinogram 6 and atrophy of RPE cells 5,7 . SRP, which also called pseudo-retinitis pigmentosa, is a kind of retinal degenerative diseases caused by primary disease, such as in ammation, trauma, retinal choroidal obstruction as well as ocular tumors 8 .…”
Section: Discussionmentioning
confidence: 99%